Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Psyence Australia Pty Ltd
Psyence Australia Pty Ltd
CytomX Therapeutics
M.D. Anderson Cancer Center
Bayer
Institut Bergonié
Sheba Medical Center
Verrica Pharmaceuticals Inc.
Mural Oncology, Inc
AstraZeneca
Exelixis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Apexigen America, Inc.
N.N. Petrov National Medical Research Center of Oncology
Melanoma Institute Australia
Novo Nordisk A/S
Hoffmann-La Roche
University Hospital Heidelberg
Eisai Inc.
miRagen Therapeutics, Inc.
Novartis
Cambridge University Hospitals NHS Foundation Trust
M.D. Anderson Cancer Center
Oncovir, Inc.
miRagen Therapeutics, Inc.
UCSF Benioff Children's Hospital Oakland
BioNumerik Pharmaceuticals, Inc.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Novartis
GlaxoSmithKline
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
National Institutes of Health Clinical Center (CC)
University of Utah
Novo Nordisk A/S
Sanofi
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Bayer
GlaxoSmithKline
Delcath Systems Inc.
Clavis Pharma
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
Novartis
Vical